This page tracks new and upcoming treatment options for breast cancer. What’s in development? What’s promising? What’s available soon? Current topics include CDK4/6 inhibitors, MYO10, and more.
Last updated:
September 19, 2021
News
- The paradigm shift led by CDK4/6 inhibitors in breast cancer Sep 19, 2021
- Ribociclib added to endocrine therapy extends survival in postmenopausal patients with metastatic breast cancer Sep 19, 2021
- Unconventional Myosin Protein Linked with Breast Cancer Response to Immune Checkpoint Blockade Sep 16, 2021